Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Unattributed VC | Alive

Total Raised


Last Raised

$100K | 16 yrs ago

About Chaperone Technologies

Chaperone Technologies, Inc. is developing antimicrobial products, based on a novel and proprietary mechanism of action, for difficult-to-treat and drug-resistant organisms across a broad range of infectious diseases. Chaperone's proven technology has already yielded the company's first product, a potent antimicrobial which is in development for treating complicated drug resistant Urinary Tract Infections.

Chaperone Technologies Headquarter Location

1200 Liberty Ridge Drive Suite 310

Wayne, Pennsylvania, 19087,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.